Tretinoin
Overview
Tretinoin is a dermatological agent used to treat acne vulgaris and acute promyelocytic leukemia. It is a derivative of vitamin A and works by modulating cell differentiation and proliferation.
API suppliers (6)
Suppliers of Tretinoin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 2 of 6 suppliers.
1 of 6 holds a GMP certificate on record in the EU or UK registers
- CHONGQING HUAPONT PHARMACEUTICAL CO LTD1 active DMF
- SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBHGermany1 active DMF
- BIOPHORE INDIA PHARMACEUTICALS PVT LTD1 active DMF
- OLON SPAItaly1 active DMF GMP on record
- RANBAXY LABORATORIES LTD
- SHANGHAI NO 6 PHARMACEUTICAL FACTORY
Patent & exclusivity (US)
Per the FDA Orange Book (38 approved US products), the latest listed US patent on Tretinoin expires 22 Aug 2038. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Do you supply Tretinoin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.